Table 1 Response to treatment
Response | Post NACT | Post CCRT | Post NACT | Post CCRT | ||||
|---|---|---|---|---|---|---|---|---|
FIGO Stage | FIGO Stage | |||||||
No. of patients (%) | (n = 50) | (n = 50) | IIB-IIIB (n = 16) | IIIC1 (n = 28) | IIIC2 (n = 6) | IIB-IIIB (n = 16) | IIIC1 (n = 28) | IIIC2 (n = 6) |
CR | 5 (10.4) | 36 (72.0) | 2 (12.5) | 2 (7.1) | 1 (16.7) | 14 (87.5) | 18 (64.3) | 4 (66.7) |
PR | 33 (68.8) | 9 (18.0) | 12 (7.5) | 17 (60.7) | 4 (66.7) | 2 (12.5) | 6 (21.4) | 1 (16.7) |
SD | 10 (20.8) | 0 (0) | 1 (6.3) | 10 (35.7) | 1 (16.7) | 0 (0) | 0 (0) | 0 (0) |
PD | 0 (0) | 5 (10.0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 4 (14.3) | 1 (16.7) |
Response rate (CR + PR) | 38 (79.2) | 45 (90.0) | 14 (87.5) | 19 (67.9) | 5 (83.3) | 16 (100) | 24 (85.7) | 5 (83.3) |
Assessment not done | 2 (4.0) | 0 (0) | 1 (6.3) | 1 (3.6) | - | - | ||